LU72652A1 - - Google Patents

Info

Publication number
LU72652A1
LU72652A1 LU72652A LU72652A LU72652A1 LU 72652 A1 LU72652 A1 LU 72652A1 LU 72652 A LU72652 A LU 72652A LU 72652 A LU72652 A LU 72652A LU 72652 A1 LU72652 A1 LU 72652A1
Authority
LU
Luxembourg
Application number
LU72652A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU72652A1 publication Critical patent/LU72652A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/16Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain
LU72652A 1974-06-04 1975-06-04 LU72652A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742426812 DE2426812A1 (en) 1974-06-04 1974-06-04 PROCESS FOR THE MANUFACTURING OF GRANULES

Publications (1)

Publication Number Publication Date
LU72652A1 true LU72652A1 (en) 1975-10-08

Family

ID=5917213

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72652A LU72652A1 (en) 1974-06-04 1975-06-04

Country Status (8)

Country Link
JP (1) JPS516869A (en)
AT (1) AT343083B (en)
BE (1) BE829449A (en)
DE (1) DE2426812A1 (en)
FR (1) FR2273584A1 (en)
GB (1) GB1513166A (en)
LU (1) LU72652A1 (en)
NL (1) NL7506615A (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
GB2287880A (en) * 1994-03-14 1995-10-04 Euro Celtique Sa Production of sustained release compositions
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
DE69332291T2 (en) * 1992-10-16 2003-07-31 Nippon Shinyaku Co Ltd METHOD FOR PRODUCING WAX MATRICES
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (en) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 Manufacturing method and sustained release composition of pharmaceutical composition
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2491572C (en) 2002-07-05 2010-03-23 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8557291B2 (en) 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
DK1765292T3 (en) * 2004-06-12 2018-01-02 Collegium Pharmaceutical Inc ABUSE PREVENTIONAL PHARMACEUTICAL FORMULATIONS
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CN110507658B (en) * 2019-09-18 2022-10-21 国药集团致君(深圳)制药有限公司 Cefuroxime axetil pharmaceutical composition and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4856577A (en) * 1971-11-22 1973-08-08

Also Published As

Publication number Publication date
GB1513166A (en) 1978-06-07
BE829449A (en) 1975-09-15
ATA415075A (en) 1977-09-15
FR2273584A1 (en) 1976-01-02
NL7506615A (en) 1975-12-08
JPS516869A (en) 1976-01-20
DE2426812A1 (en) 1976-01-02
AT343083B (en) 1978-05-10

Similar Documents

Publication Publication Date Title
DK151975A (en)
FR2266865A2 (en)
JPS50125551A (en)
JPS50112820A (en)
AR199089A1 (en)
AU495844B2 (en)
FR2270053B1 (en)
JPS50108470U (en)
JPS50132071A (en)
JPS50139411U (en)
JPS5113064U (en)
AU7474374A (en)
JPS50107649A (en)
JPS50101867A (en)
BG27047A4 (en)
BG20665A1 (en)
BG21791A1 (en)
BG22011A1 (en)
BG22387A3 (en)
BG22667A1 (en)
BG20849A1 (en)
BG26192A3 (en)
BG26358A3 (en)
BG26402A3 (en)
CH571614B5 (en)